Skip to main content

German watchdog calls for direct comparison of cancer immunotherapies

FRANKFURT, Jan 15 (Reuters) - Germany's drug assessment body has criticised a lack of data directly comparing drugs in a promising new class of cancer immunotherapy, saying physicians could be overwhelmed or misled by the available information.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.